Bone Therapeutics

About:

Bone Therapeutics is a biopharmaceutical company developing cell therapy products for the treatment of osteo-articular diseases.

Website: http://www.bonetherapeutics.com

Twitter/X: BoneTherapeutic

Top Investors: European Investment Bank, Life Sciences Research Partners V.Z.W., Nausicaa Ventures, BAMS Angel Fund

Description:

Bone Therapeutics is a international biopharmaceutical company focused on innovative cell therapy products for the treatment of bone diseases. Utilizing the Company's unique knowledge of the bone/joint physiology and long-standing expertise in cell therapy and cell transplantation, Bone Therapeutics has created a fully integrated business with an advanced product pipeline comprising novel bone cell products, tailored in-house production methods, and minimally invasive treatment techniques.

Total Funding Amount:

68.6M EUR

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Gosselies, Hainaut, Belgium

Founded Date:

2006-01-01

Contact Email:

info(AT)bonetherapeutics.com

Founders:

Enrico Bastianelli

Number of Employees:

101-250

Last Funding Date:

2021-12-03

IPO Status:

Delisted

Industries:

© 2025 bioDAO.ai